SCHEMBL4239274

SCHEMBL4239274

CC1(C)c2ccccc2-c2cc3c(-c4ccc5ccccc5c4)c4ccc(-c5ccc6ccccc6c5)cc4c(-c4ccc5ccccc5c4)c3cc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 1/20 0.36
LIPG Q9Y5X9 1/20 0.36
HDAC4 P56524 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
GSTP1 P09211 1/20 0.34
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
ALOX5 P09917 1/20 0.33
PTGER3 P43115 3/20 0.33
IKBKB O14920 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6521126 0.95 HDAC4 (0.37) LPLLIPGHDAC4HDAC2HDAC8
SCHEMBL25585945 0.92 LPL (0.36) LPLLIPGHDAC4HDAC2HDAC8
SCHEMBL26860176 0.92 LPL (0.36) LPLLIPGHDAC4HDAC2HDAC8
SCHEMBL2381917 0.90 CYP2A6 (0.37) LPLLIPGHDAC4HDAC2HDAC8
SCHEMBL25591788 0.89 LPL (0.38) LPLLIPGHDAC4HDAC2HDAC8
SCHEMBL2379615 0.88 HDAC4 (0.33) LPLLIPGHDAC4HDAC2HDAC8
SCHEMBL27070858 0.88 PDK2 (0.39) LPLLIPGHDAC4HDAC2HDAC8
SCHEMBL13488051 0.86 SMN1; SMN2 (0.34) LPLLIPGHDAC4HDAC2HDAC8
SCHEMBL13488045 0.86 PDK2 (0.41) LPLLIPGHDAC4HDAC2HDAC8
SCHEMBL13487652 0.86 PDK2 (0.36) LPLLIPGHDAC4HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2388843-B1 Organic material and organic light emitting diode display using same SAMSUNG DISPLAY CO LTD (KR) 2019-08-07 EP disclosed
WO-2014104666-A1 INK COMPOSITION FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT USING SAME 주식회사 두산 (KR) 2014-07-03 WO disclosed
US-8395144-B2 Anthracene derivatives and organic electroluminescent device using same DOOSAN CORPORATION (KR) 2013-03-12 US disclosed
US-20110057182-A1 ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME DOOSAN CORPORATION (KR) 2011-03-10 US disclosed
WO-2009139580-A2 ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME 주식회사 두산 (KR) 2009-11-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110057182-A1 ANTHRACENE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME TRPA1, AHR, ORAI2 LPL 2685/4885LIPG 2621/4885HDAC4 2884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.